Catalyst Wire Dossier Catalyst Wire Dossier

NewGam 10% Intravenous Immunoglobulin

intravenous immunoglobulin (human) 10% solution · Octapharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NewGam 10% Intravenous Immunoglobulin, covering 2017-03-29 to 2017-03-29. Get the full timeline:

Most recent: Clinical Trial Update: High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) [Phase 3]

See pricing